Liad Whatstein

Liad Whatstein

Liad Whatstein


Liad is one of Israel’s best-known and most respected IP lawyers and has been involved in some of Israel’s most complex and widely publicized patent, trademark and copyright disputes. Liad is broadly recognized by clients, peers and international directories as one of Israel’s most successful litigators. He has litigated cases for most innovative pharmaceutical companies in connection with many blockbuster drugs, supervised complex experiments and has worked extensively with some of the world’s leading experts. In addition, Liad is extensively involved in patent prosecution work and leverages his unrivalled litigation experience to obtain enforceable patents and develop creative prosecution strategies. Liad also represents many of the world’s leading brand owners in enforcing their trademarks and litigated some of Israel’s landmark copyright cases.
Liad has been consistently described by Chambers, Legal 500, IAM, WHO’S WHO, WTR and other leading directories as a “truly great litigator” and a “celebrated name” who knows how to deliver results to clients. Liad is also a prolific writer and was the Chairman of the IP Chapter of the Israel Bar Association.
Liad is a graduate of the Tel Aviv University (LL.B., Cum Laude, 1990) and the London School of Economics and Political Science (LL.M., with Merit, 1992) and a graduate of the Computer Science Academy of the Israel Defense Forces. Prior to practicing law, Liad was a system programmer on IBM mainframe computers at the Israeli Airforce. Liad likes spending time with his children whenever he can and is passionate about late romantic classical music and opera. In addition, Liad provides pro bono legal services to Israeli artists, authors and poets.
Representative list of accolades:
  • “Liad Whatstein & Co is the prime address in the region for major innovative pharmaceutical companies needing support on contentious matters… Liad Whatstein is a truly outstanding litigator – dedicated, intelligent, strategic, experienced, hardworking and responsive. He has great technical understanding – and his ability to communicate complex scientific concepts in simple language is remarkable… There is simply no better lawyer in the country” (IAM 1000, 2018);
  • “Liad Whatstein is one of the best patent litigators in Israel and is applauded for his significant experience in representing originators” (Who’s Who Legal, Life Sciences, 2018);
  • “Liad Whatstein is a renowned name in the life science sphere who receives plaudits for his brilliant practical advice on both transactional and contentious issues” (Who’s Who Legal, Life Sciences, 2018);
  • “Liad Whatstein is recognised by the market as a brilliant litigator” (Chambers & Partners, 2018);
  • “Liad Whatstein is a courtroom celebrity” (WTR 1000, 2018);
  • “Liad Whatstein is outstanding, diligent and very responsive” (Chambers & Partners, 2017);
  • “Name partner Liad Whatstein has orchestrated scores of ground-breaking victories and is an authority on the life sciences” (IAM 1000, 2017);
  • “Liad Whatstein is unquestionably one of the most respected litigators in the country” (WTR 1000, 2017);
  • “Liad Whatstein is a standout patent litigator” (Legal 500, 2016);
  • “Liad Whatstein is an excellent litigator in patent litigation” (Chambers & Partners, 2016);
  • “Liad Whatstein provides strong leadership to the litigation team. His arguments go straight to the point and he has excellent courtroom skills. He is an aggressive and very tough litigator, but he has common sense and knows how to settle cases” (WTR 1000, 2015);
  • “Liad Whatstein remains a ruthless, very sharp, very dominant litigator, yet cooperative in transactions despite being a contentious lawyer at heart” (IAM 1000, 2015);
  • “Liad Whatstein stands out on the contentious side” (Legal 500, 2015);
  • “He is an esteemed patent litigator, praised for his proactivity and good preparation. He covers patent, trade mark and copyright issues, with a focus on the pharmaceutical and IT sectors” (Chambers & Partners, 2015);
  • “Liad Whatstein is a widely respected patent litigator” (Legal 500, 2014);
  • “Liad Whatstein is a celebrated name on the market: He is extremely knowledgeable about his clients’ technology and first-class on all the legal and procedural issues associated with oppositions in Israel” (IAM 1000, 2014);
  • “Liad Whatstein is lauded by clients as a technically skilled patent litigation expert who is very engaged in his cases. Sources praise his experience and great insights into the strategies applied by local generic competitors” (Chambers & Partners, 2014);
  • “Liad Whatstein is dedicated to obtaining the best possible results for rights holders. He is practical, proactive and diligent, and truly understands what companies are looking for in their external counsel. He is a wonderful partner and a pleasure to work with” (WTR 1000, 2014);
  • “Patrons entrust their most complex mandates to the safe hands of supremely effective litigator Liad Whatstein. Proactive, incredibly knowledgeable about the system and a pragmatic adviser, he enjoys great success in both contentious and transactional matters” (IAM 1000, 2012);
  • “The excellent Liad Whatstein has a prodigious reputation as a litigator” (IAM 250, 2011);
  • “Liad Whatstein is a truly great litigator” (WTR 1000, 2011);
  • “A superb litigator – one of the best in Israel” (Chambers & Partners, 2009);
  • “Liad Whatstein is really creative and successful on a strategic level” (Chambers & Partners, 2009);
  • “Liad Whatstein is an excellent jurist who is extremely intelligent and very well prepared in court” (Chambers & Partners, 2008);
  • “Liad Whatstein is a tough litigator and a pleasant adversary” (Chambers & Partners, 2008);
  • “Liad Whatstein is an excellent jurist who is extremely intelligent and very well prepared in court” (Chambers & Partners, 2008);
  • “Liad Whatstein is a tough litigator and a pleasant adversary” (Chambers & Partners, 2008).
Publications:
  • Israel Chapter in “Life Sciences Global Guide: Medicinal product regulation and product liability” (Thomson Reuters Practical Law, 2018, https://uk.practicallaw.thomsonreuters.com/w-016-6339);
  • Israel Chapter in “The International Comparative Legal Guide to: Copyright 2019” (Global Legal Group, 2018, https://iclg.com/practice-areas/copyright-laws-and-regulations/israel);
  • Israel Chapter in “Life Sciences Global Guide: Pharmaceutical IP and competition law” (Thomson Reuters Practical Law, 2018, https://uk.practicallaw.thomsonreuters.com/w-014-5548);
  • Israel Chapter in “The International Comparative Legal Guide to: Pharmaceutical Advertising 2018” (Global Legal Group, 2018, https://iclg.com/practice-areas/pharmaceutical-advertising-laws-and-regulations/israel);
  • Israel Chapter in “IP in Life Sciences” (Globe Business Publishing, 2015);
  • Israel Chapter in “Global Patent Litigation” (Kluwer Law International, 2015);
  • Israel Chapter in “Patent Transactions in the Life Sciences” (Globe Business Publishing, 2014);
  • Israel Chapter in “E-Discovery and Data Privacy: A Practical Guide” (Wolters Kluwer, 2010);
  • Israel Chapter in “Copyright: Global Law and Practice” (Sweet and Maxwell, 2003);
  • Chapter on Publishing License Agreements in “International Licensing” (BNA, 2000);
  • Israel Chapter in “Worldwide Trade Secrets Law” (Clark Boardman, 1994);
  • “Patent Term Extension Under Israeli Law,” Who’s Who Legal (May 2011);
  • “Customs Border Measures Around the Mediterranean, Part II,” Vol. 66, Issue 2 of INTA Bulletin, January 15, 2011;
  • “Customs Border Measures Around the Mediterranean, Part I,” Vol. 66, Issue 1 of INTA Bulletin, January 1, 2011;
  • “Israeli Trademark Practice: Practical Approach with International Flavor,” Vol. 65, Issue 16 of INTA Bulletin, September 15, 2010;
  • “Will the Legislator Follow the Courts in IP Matters?” 23 Journal of the Israel Bar Association 58, 2001;
  • “State Assistance for Patent Violation” 26 Journal of the Israel Bar Association 48, 2001;
  • “Extraterritorial Application of EC Competition Law – Comments and Reflections”, 26 Israel Law Review 195, 1992.